Literature DB >> 13567489

[Spiramycin therapy of experimental toxoplasmosis in mice].

J P GARIN, D E EYLES.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/effects; TOXOPLASMOSIS/experimental

Mesh:

Substances:

Year:  1958        PMID: 13567489

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0032-7867            Impact factor:   1.228


× No keyword cloud information.
  15 in total

1.  Spiramycin for Toxoplasmosis.

Authors:  J V Cassady; J W Bahler; M V Hinken
Journal:  Trans Am Ophthalmol Soc       Date:  1963

Review 2.  Toxoplasmosis.

Authors:  J K Beverley
Journal:  Br Med J       Date:  1973-05-26

3.  Toxoplasmosis in pregnancy and its transmission to the fetus.

Authors:  G Desmonts; J Couvreur
Journal:  Bull N Y Acad Med       Date:  1974-02

4.  Treatment of active toxoplasmic retino-choroiditis.

Authors:  J Nolan; E S Rosen
Journal:  Br J Ophthalmol       Date:  1968-05       Impact factor: 4.638

5.  Effect of clindamycin on acute and chronic toxoplasmosis in mice.

Authors:  F G Araujo; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

6.  In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.

Authors:  F G Araujo; R M Shepard; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

7.  Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.

Authors:  B T Nguyen; S Stadtsbaeder
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

8.  Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.

Authors:  S Chamberland; H A Kirst; W L Current
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

9.  Effect of roxithromycin on acute toxoplasmosis in mice.

Authors:  H R Chang; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

Review 10.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.